A Game-Changing Class of Venture Investment
Gary Magnant, Manager, is a Boston-based serial biotechnology entrepreneur with a successful track record of starting, building and selling life science companies for more than 25 years. He conceived of and developed the Venture Engineering process and principles used by the Fund to manage portfolio company risks, build power-broker teams and exit faster than Venture Capital funds. Gary is the brainchild and co-founder of several successful biotech companies, including Owl Scientific (assigned by ThermoFisher, NYSE: TMO), Sage Science (Beverly, MA) and Thrive Bioscience (Wakefield, MA). He was also a co-founder of two venture-backed startup companies, ActivBiotics (>$100M invested) and ThermoCeramix ($>10M invested) which failed under the Venture Capital model and drove much of Gary’s inspiration for a better early stage investment model.
Gary is currently interim CEO and Venture Engineer at TriBiotica, a Triple Sharp portfolio company. He is a former chairman and member of the Board of Trustees of Stoneridge Montessori (now Harborlight Montessori), and a recipient of the institution’s most prestigious community service award, The Hallowell Award. Gary is the inventor on numerous life science and advanced materials patents, including a patent issued in 2017 covering an advanced cell and tissue culture systems.
Robert Smith, Manager, entered Wall Street over 20 years ago with lessons passed down from four generations of family members who worked in the investment industry before him. For more than a decade, Robert has allocated capital on behalf of and co-invested with Family Offices. Over the course of his career, he managed sales and trading teams at leading financial institutions, where he built a Fund Investor network and led in profitability at three firms: once while working in a trading capacity at the world’s largest market making firm and twice while working in an equity capital markets capacity at boutique investment banks. In 2014, Robert founded ICV to bring together his network of Family Offices and Fund Investors to evaluate opportunities that create a social impact beyond a financial return. Robert serves as Business Strategy Advisor to New Frontier Bio, a multi-asset holding company, which leverages the long-term involvement of the Kennedy family in healthcare to identify, finance and develop novel medical technologies from inception through clinical proof of concept. He serves as a member of the President’s Advisory Board of Thomas Jefferson University and Jefferson Health, 16th on U.S. News & World Report’s 2017-2018 Best Hospitals Honor Roll. Robert is Senior Advisor for Fundraising and Partnerships to the Permanent Secretariat of the World Summit of Nobel Peace Laureates. He is a member of the Advisory Council of Represent.Us., a Trustee of The Children’s Village and the Africa Rising Foundation. Robert serves as a member of the Board of Directors of the Chaeli Foundation, Childhood Cancer Kids, Together for Girls and Tuesday’s Children. Robert is also Vice President and a member of the Board of Directors of The Harmon Foundation, a private foundation established in 1922 by his great, great grandfather, William E. Harmon, who operated the largest real estate company in the world at the turn of the 20th century, created the mortgage and college loans, fueled the Harlem Renaissance and donated to thousands of nonprofits over his lifetime “to bring smiles and tender thoughts to the great in heart in high and low places, and to comfort and cheer those who do exceptional things or suffer.” In 2018, Robert was recognized as one of The 100 Visionary Leaders leading us towards a better world by Real Leaders Magazine. He was also inducted as a member of Evolutionary Leaders, a network of people who feel a sense of urgency about the state of our world and are forging a movement for the conscious evolution of humanity.
Rahul Bhansali, Chief Operating Officer, is a dynamic, curious, and analytically-minded tech entrepreneur and marketer that founded / co-founded three companies in organic food home delivery, physical commodity trade consulting, and industrial safety technology. Most recently, he co-founded StrongArm Technologies (~$10m invested). There, he delivered a machine learning / IoT technology that is shown to produce massive savings for enterprise clients, to companies including some of the largest courier, retail, and ecommerce companies in the world. He orchestrated the creation of its category, Industrial BioTelemetrics, to improve safety and productivity of millions of workers worldwide. He has seen firsthand the pitfalls and inefficiencies of the Venture Capital model, instilling in him a passion to operate an improved early stage investment model. As Director of Indlak Group, Rahul has managed a number of his family’s enterprises. After bringing his foray into organic agriculture, Ehsaas Organic, well into profitability, he integrated it into his family companies. The Bhansali Family’s business assets, primarily located in India, are spread across a number of activities such as international trade, footwear manufacturing, real estate development, hospitality, and organic food production & lifestyle products. Rahul has an MBA from Babson, is an oil painter, is trained in Socratic method-based dialogue facilitation, and practices deep insight meditation.
W. Adam Hill is the Chief Technology Officer of Triple Sharp Venture Engineering, LLC. He is focused on positively impacting patients’ lives and bringing efficiency and effectiveness to discovering new medicines.
Adam is a pioneer in the implementation of new technologies to effect greater efficiencies in life sciences. Prior to joining Triple Sharp, Adam served as a long-time head of drug screening for Novartis, one of the top pharmaceutical companies in the world. In this role, Adam advanced new compounds into clinical development and evaluated new drug discovery technologies. He also served as a managing scientist at Millennium Pharmaceuticals and Schering-Plough.
Adam received his D. Phil, Chemistry & Pharmacology, from the University of Oxford and conducted post-doctoral research at Harvard University and the University of Connecticut.
Justin Topp, an Assistant Dean and Professor of Bioengineering and Biology at Endicott College, is a Navigator on several startups. A teacher, scholar, innovator and mentor, he leads an inter-disciplinary team of nearly 20 full-time faculty responsible for eight undergraduate and graduate programs in science, engineering and technology. With broad research experience in molecular biology, biochemistry and cell biology, Justin has performed pioneering studies on Alsin, a protein mutated in childhood neurodegenerative disorders. He has raised more than $6M in grants and private donations, and mentors startup companies in fundraising, team formation and technology development.
An avid connector and collaborator, Justin was instrumental in the formation and operation of the Life Sciences Consortium of the North Shore, a five-institution organization innovating education to promote success of the local life sciences ecosystem. Justin received his B.S.E. in Biomedical Engineering from the University of Iowa and a Ph.D. in Biological Chemistry from the University of Texas-Southwestern Medical Center. He also pursued two postdoctoral fellowships that included working on cholesterol homeostasis with Nobel Prize-winning scientists Michael Brown and Joseph Goldstein.
Irwin Heller was Managing Partner of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, PC for six years. Irwin’s practice includes a diversified clientele ranging from start-up to publicly traded entities.
He is involved with joint ventures, product development and marketing agreements designed to advance the interests of multiple parties. Irwin serves as a Board Advisor to BiOWiSH Technologies Inc., and as a Member of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., Boston office.
Irwin is a past Trustee of Tufts University and served as the President and Trustee of Temple Beth Elohim of Wellesley. He also served as a Trustee of the Wang Center and is a founder and Board member of Commonwealth Shakespeare Company. He is admitted to practice in Massachusetts and is a Member of the American, Massachusetts and Boston Bar Associations. Irwin has a B.A. from Tufts University and J.D., cum laude, from Columbia University Law School.
“Goodness is the only investment that never fails.”
– Henry David Thoreau